DASSAULT SYSTEMES SA ADR - DASTY STOCK NEWS

Dassault Systèmes disclosed its trading in own shares from December 20 to December 24, 2021, as per the repurchase program approved on May 26, 2021. During this period, a total of 8,789 shares were repurchased at a weighted average acquisition price of €50.78. The trading took place on two markets: XPAR and DXE. For further details and transaction specifics, investors can refer to their official website.

Dassault Systèmes disclosed its share repurchase activities from December 14 to December 17, 2021, as approved in the General Meeting of Shareholders on May 26, 2021. The transactions included a total of 71,000 shares purchased at a weighted average price of 51.77 on XPAR on December 14, followed by further acquisitions of 61,000 shares at 51.72, 18,000 shares at 51.73 and a total of 40,149 shares at prices ranging from 50.96 to 50.98 on December 17.

Dassault Systèmes disclosed the total number of its outstanding shares and voting rights as of November 30, 2021, in compliance with the Autorité des marchés financiers regulations. The company reported 1,332,321,185 outstanding shares and 1,992,862,422 voting rights. The calculation of voting rights is based on the total number of outstanding shares, as stipulated in Article 223-11 of the regulations. Shareholders needing to declare crossing of thresholds are advised to contact the Investors Relations Service.

Dassault Systèmes announced the total number of its outstanding shares and voting rights as of October 31, 2021. The number of outstanding shares is 1,331,886,457, and the total number of voting rights is 1,992,515,631. This announcement aligns with the regulations set by the Autorité des marchés financiers. Shareholders are reminded to refer to Article 223-11 regarding the calculation of voting rights. Declarations concerning crossing thresholds can be submitted to the company's Investor Relations.

NantHealth, Inc. (NASDAQ: NH) has appointed three new executives to enhance its leadership team: Jerry Magin as Senior VP of Global Sales and Marketing, Neil Carpenter as Senior VP of Strategy, and Arlyn Small as Senior VP of Human Resources. Magin brings over 25 years of experience in building sales and marketing teams, Carpenter has extensive expertise in healthcare strategy, while Small has a strong background in HR across multiple sectors. These appointments aim to drive growth and innovation at NantHealth, as stated by COO Ron Louks.

Information Services Group (Nasdaq: III) reported strong growth in the EMEA technology and business services market. The combined annual contract value (ACV) reached a record $6.5 billion, marking a 36% increase year-over-year. As-a-service ACV surged 59% to $3.3 billion, while managed services ACV grew 19% to $3.2 billion but showed a decline for the third consecutive quarter. For the year-to-date, the combined market generated $19.1 billion, a 27% increase, driven by significant activity in IaaS and SaaS solutions.

Dassault Systèmes reported robust third-quarter 2021 results, with total revenue soaring 12% to €1.16 billion. Diluted EPS increased 94% to €0.14, while non-IFRS EPS grew 40% to €0.22. Strong performance was particularly noted in Licenses and other software revenue, which rose 24%. The company raised its full-year guidance, projecting revenue growth of 10%-11% and EPS growth of 25%-27%. Operating margin improved to 33.8%, up from 28.2% year-on-year. Cash flow from operations increased by 24.5% to €1.25 billion, reflecting strong business momentum across various industries.

Dassault Systèmes will announce its operating performance for Q3 2021 on October 28, 2021. The webcast starts at 10:00 AM Paris time and a conference call follows at 9:00 AM New York time. Both events will be accessible live and archived on Dassault Systèmes’ investor website. The company, a leader in 3D design and PLM solutions, serves over 290,000 customers globally. With 20,000 employees across more than 140 countries, Dassault Systèmes continues to foster innovation through its 3DEXPERIENCE platform.

Tarek Sherif, co-founder of Medidata and Life Sciences & Healthcare Sector Board Chairman for Dassault Systemes, joins the board of directors at Florence. With over 20 years of experience, including leading Medidata to an IPO and acquiring it for $5.8B, Sherif aims to enhance Florence's position in clinical research. The company, serving over 10,000 trial sites in 44 countries, recently raised $80M in a Series C funding round to improve trial site efficiencies and connectivity in clinical development.